- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02001922
Soins intégrés BPCO (Broncho-pneumopathie Chronique Obstructive) en Valais - Mieux Vivre Avec ma BPCO (COPD Integrated Care Program Valais - Living Well With COPD)
COPD Integrated Care Program Valais - Living Well With COPD, a Pilot Study Assessing Feasibility, Acceptability and Effectiveness in the Canton of Valais, Switzerland
Background: Chronic obstructive pulmonary disease (COPD) is a progressive respiratory disorder characterized by acute exacerbations that contribute to physical impairment and increased healthcare use and costs. Given the increasing burden of this disease in terms of morbidity, disability, mortality and costs, innovative care models centered on patients and aiming at improving quality and comprehensiveness of care are needed. Effective implementation and evaluation of chronic disease management - integrated care(CDM-IC) programs, in the real world context is of great importance.
Aim of the pilot study: To conduct a pilot study assessing the acceptability, feasibility and effectiveness of a community-based CDM-IC program for COPD patients residing in the canton of Valais.
Design: The evaluation plan of this study will combine both quantitative (controlled before-after study design) and qualitative methods (focus groups with COPD patients and practicing healthcare professionals).
Setting: French-speaking part of the canton of Valais.
Patients: 50 adult (>35 years) COPD patients GOLD stage I (symptomatic) - IV of the disease, non-institutionalized and residing in the canton of Valais. The control group of patients will be constituted of age and gender-matched COPD patients from the Swiss COPD cohort study.
Measures:
Quantitative part:
Primary outcomes: Generic and disease-specific health-related quality-of-life and all-cause hospitalizations (past 12 months)
Other outcomes:
- Processes of care
- Patients' assessment of how care is congruent with the Chronic Care Model (PACIC instrument)
- Measure of self-efficacy (intermediary outcome)
- 6-minutes walking test, nb of COPD exacerbations, % of current smokers
- Healthcare utilization: unscheduled ambulatory care visits
- Care satisfaction
- Measures of the process of implementation of the intervention
Qualitative part: At 12 months: conduct of two focus groups of participating COPD patients, and of two focus groups of participating healthcare professionals.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background: Chronic obstructive pulmonary disease (COPD) is a progressive respiratory disorder characterized by acute exacerbations that contribute to physical impairment and increased healthcare use and costs. Given the increasing burden of this disease in terms of morbidity, disability, mortality and costs, innovative care models centered on patients and aiming at improving quality and comprehensiveness of care are needed. Effective implementation and evaluation of chronic disease management - integrated care(CDM-IC) programs, in the real world context is of great importance.
Aim of the pilot study: To conduct a pilot study assessing the acceptability, feasibility and effectiveness of a community-based CDM-IC program for COPD patients residing in the canton of Valais.
Design: The evaluation plan of this study will combine both quantitative and qualitative methods. A controlled before-after study design will be considered for the quantitative part of the project, and the qualitative part will include the conduct of focus groups with COPD patients and practicing healthcare professionals.
Setting: French-speaking part of the canton of Valais.
Patients: 50 adult (>35 years) COPD patients GOLD stage I (symptomatic) - IV of the disease, aged > 35 years, non-institutionalized and residing in the canton of Valais. Patients will be recruited by primary care and pulmonary care physicians practicing in the French-speaking part of the canton of Valais. The control group of patients will be constituted of age and gender-matched COPD patients already included in the Swiss COPD cohort study.
Measures:
Quantitative part:
Primary outcomes: Generic and disease-specific health-related quality-of-life(Chronic Respiratory Questionnaire (CRQ), SF-36 and COPD Assessment Test (CAT)) and all-cause hospitalizations (past 12 months)
Other outcomes:
- Processes of care (% patients having participated to self-management education sessions, % patients having received/used the action plan, % patients having received smoking cessation recommendations, % patients having received advices/participated to participate to pulmonary rehabilitation, % patients having received influenza immunization during the past 12 months, % patients receiving appropriate treatment, nb of consultations with primary care physician/pulmonary care physician/other, nb of contacts with the hotline)
- Patients' assessment of how care is congruent with the Chronic Care Model (PACIC instrument)
- Measure of self-efficacy (intermediary outcome)
- Health behaviors, symptoms and physical activity measures: 6-minutes walking test, nb of COPD exacerbations during past (past 12 months), % of current smokers
- Healthcare utilization: unscheduled ambulatory care visits
- Care satisfaction
- Measures of the process of implementation of the intervention (nb of recruiting practices and physicians, nb of participating practices and physicians, nb of and patients, of drop-outs, satisfaction of healthcare professionals towards COPD program)
Qualitative part: conduct of two focus groups of participating COPD patients, and of two focus groups of participating healthcare professionals, 12 months after the start of the recruitment.
Development and implementation of the intervention:
The development of the current COPD program in Valais is being implemented in collaboration with physicians working in private practices (family physicians and specialists), physiotherapists, pharmacists and nurse specialists. It will involve academic and public institutions, as well as practitioners. The program has been launched in March 2013, after a preliminary phase involving the conduct of focus groups. Their aims were to explore the needs and barriers to better care, as well as the shape of the targeted CDM elements for better implementation in real life, from the point of view of COPD patients and healthcare professionals.
The CDM intervention considered in the "Soins intégrés BPCO en Valais - Mieux vivre avec ma BPCO" program is based on the " Living well with COPD programme " developed by Prof. Bourbeau & al at McGill University, Montreal, Canada. The "Soins intégrés BPCO en Valais - Mieux vivre avec ma BPCO" program will include a combination of patient-related, professional and organizational elements. It will be centered on patients' needs and focus on self-management education, proactive follow-up (scheduled visits and/or phone contacts), team work, healthcare professionals' training, and promotion of pulmonary rehabilitation, physical activity as well as smoking cessation.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Valais
-
Crans Montana, Valais, Switzerland, 3963
- Centre Valaisan de Pneumologie, Centre Hospitalier du Centre du Valais
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Diagnosis of COPD (GOLD stage 1-symptomatic to 4)
- Age >= 35 years
- Residing in the canton of Valais Switzerland, non-institutionalized
- Informed consent
Exclusion Criteria:
- Hospitalization during previous 4 weeks
- Pulmonary rehabilitation during past 18 months
- Estimated life expectancy < 12 months
- Obvious cognitive impairment
- Not speaking or understanding French well enough
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: COPD integrated care
The intervention will target COPD integrated care, and include a combination of patient-related, professional and organizational elements.
It will be centered on patients' needs and focus on self-management education, proactive follow-up (scheduled visits and/or phone contacts), team work, healthcare professionals' training, promotion of pulmonary rehabilitation, physical activity and smoking cessation.
|
The intervention will target COPD integrated care, and include a combination of patient-related, professional and organizational elements.
It will be centered on patients' needs and focus on self-management education, proactive follow-up (scheduled visits and/or phone contacts), team work, healthcare professionals' training, promotion of pulmonary rehabilitation, physical activity and smoking cessation.
|
No Intervention: Usual care
Usual COPD care
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Generic and disease-specific health-related quality-of-life (Chronic Respiratory Questionnaire (CRQ), SF-36, COPD Assessment Test (CAT))
Time Frame: 12 months
|
12 months
|
All-cause hospitalizations (past 12 months)
Time Frame: 12 months
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Processes of care, patient assessment of chronic illness care (PACIC)
Time Frame: 12 months
|
12 months
|
6-minutes walking test
Time Frame: 12 months
|
12 months
|
COPD exacerbations
Time Frame: 12 months
|
12 months
|
% smokers
Time Frame: 12 months
|
12 months
|
Other Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Self-efficacy
Time Frame: 12 months
|
12 months
|
Healthcare utilization
Time Frame: 12 months
|
12 months
|
Care satisfaction
Time Frame: 12 months
|
12 months
|
Process of implementation of the intervention
Time Frame: 12 months
|
12 months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Isabelle Peytremann-Bridevaux, MD, MPH, DSc, Lausanne University Hospital
- Principal Investigator: Bernard Burnand, MD, MPH, Lausanne University Hospital
- Principal Investigator: Jean-Marie Tschopp, MD, Centre Hospitalier du Centre du Valais
- Principal Investigator: Pierre-Olivier Bridevaux, MD, MSc, Centre Hospitalier du Centre du Valais
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- COPD Integrated Care Valais
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Obstructive Pulmonary Disease (COPD)
-
University College, LondonUniversity of Cambridge; National Institute for Health Research, United Kingdom and other collaboratorsUnknownChronic Obstructive Pulmonary Disease (COPD).United Kingdom
-
Reham Mohammed ElmorshedyCompletedChronic Obstructive Pulmonary Disease(COPD)Egypt
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD).United Kingdom
-
Virginia Commonwealth UniversityFisher and Paykel HealthcareCompletedChronic Obstructive Pulmonary Disease(COPD)United States
-
Medtronic BRCUnknownCOPD | COPD Exacerbation
-
Beaumont HospitalAerogenCompletedChronic Obstructive Pulmonary Disease | COPD | COPD Exacerbation | Copd Exacerbation AcuteIreland
-
Chiesi Farmaceutici S.p.A.CompletedModerate to Severe Chronic Obstructive Pulmonary Disease (COPD)Bulgaria, Germany, Hungary, Poland, Russian Federation, United Kingdom
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary Disease (COPD) | COPDUnited Kingdom
-
Elpen Pharmaceutical Co. Inc.Completed
-
Aalborg UniversityCompletedChronic Obstructive Pulmonary Disease | COPD | COPD Exacerbation | COPD Exacerbation AcuteDenmark
Clinical Trials on COPD integrated care
-
European Pathway AssociationKU Leuven; University of Eastern PiedmontCompletedPulmonary Disease, Chronic Obstructive
-
University of California, San FranciscoNational Heart, Lung, and Blood Institute (NHLBI)RecruitingCOPD (Chronic Obstructive Pulmonary Disease)United States
-
China-Japan Friendship HospitalNot yet recruitingChronic Obstructive Pulmonary Disease
-
University of ChicagoCOPD Foundation; Society of Hospital Medicine; Onda Collective; The Hospital Medicine...Recruiting
-
University of AlbertaAlberta Health services; University of Calgary; Alberta Innovates Health SolutionsCompletedPulmonary Disease, Chronic ObstructiveCanada
-
Scott & White Health PlanCompletedChronic IllnessUnited States
-
University of Alabama at BirminghamRecruiting
-
Wake Forest University Health SciencesCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Universitätsklinikum Hamburg-EppendorfRecruitingSchizophrenia | Schizoaffective Disorder | Schizophreniform Disorder | Bipolar Disorder | Delusional Disorder | Psychotic Disorder NOS | Severe Major Depression With Psychotic FeaturesGermany
-
The George Institute for Global Health, ChinaNational Institute of Mental Health (NIMH); Peking University Sixth HospitalCompletedDepression | Acute Coronary SyndromesChina